openPR Logo
Press release

Investigation announced for Long-Term Investors in Allakos Inc. (NASDAQ: ALLK)

06-09-2020 05:01 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Allakos Inc. (NASDAQ: ALLK) shares.

An investigation on behalf of current long term investors in Allakos Inc. (NASDAQ: ALLK) shares.

An investigation was announced. for long-term investors in shares of Allakos Inc. (NASDAQ: ALLK) concerning potential breaches of fiduciary duties by certain directors and officers of Allakos Inc.

Investors who are current long term investors in Allakos Inc. (NASDAQ: ALLK) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: ALLK stocks follows a lawsuit filed against Allakos Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: ALLK stocks, concerns whether certain d directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that the Company’s ENIGMA Trial for its flagship drug, AK002, was poorly designed, that Allakos cherrypicked timeframes and to engineer results for the ENIGMA trial, that Allakos used superficial endpoints in the ENIGMA Trial relative to FDA guidance, that Allakos misrepresented the number of adverse incidents that occurred during the ENIGMA Trial, that the ENIGMA Trial was not well-controlled, that Allakos failed to report key data from the ENIGMA Trial, and that as a result, defendants’ statements about Allakos’ business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Those who purchased shares of Allakos Inc. (NASDAQ: ALLK) have certain options and should contact the Shareholders Foundation.

Media Contact:
Christopher Clausen
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in Allakos Inc. (NASDAQ: ALLK) here

News-ID: 2069988 • Views:

More Releases from Shareholders Foundation

Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to recover losses
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover losses
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc.. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Malvern, PA based Ocugen, Inc., a
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV
Investigation announced for Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) over possible Violations of Securities Laws
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Allakos

Vernal Keratoconjunctivitis Market Detailed In New Research Report 2022 | Santen …
The exclusive research report on 'Vernal Keratoconjunctivitis Market' now available with 𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, offers a detailed analysis of the factors influencing the global business sphere. This report also provides precise information pertaining to market size, commercialization aspects and revenue estimation of this business. The report further elucidates the status of leading industry players thriving in the competitive spectrum of the Vernal Keratoconjunctivitis Market. The research report incorporates a detailed evaluation
Vernal Keratoconjunctivitis Market Expected to Expand at a Steady 2022-2028 | Sa …
Vernal Keratoconjunctivitis Market Report 2022 cover complete modest view with the market stake and company profiles of the important contestants working in the worldwide market. The Vernal Keratoconjunctivitis market offers a summary of product specification, production analysis, technology, product type, considering key features such as gross, gross margin, revenue, cost. Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/4657 Vernal Keratoconjunctivitis Market report provides key statistics on the Market status of the Vernal Keratoconjunctivitis
Nasal Polyposis Drug Market New Study Offers Insights for 2027 Covid-19 Analysis …
This Nasal Polyposis Drug market research stud offers proper industry viewpoint, market size, growth, future trends and trading. All this are taken into consideration while preparing the market report with the forecast period from 2021 to 2027. This report contains a complete and generic market scenario along with the factors that may have a great effect on it. Market entrance methodologies, industrial processes chain structure and rate of growth
Vernal Keratoconjunctivitis Market Competitive Insights 2021 - 2026 | Allakos, …
The report provides an overview of the many approaches employed to retain their place in the Vernal Keratoconjunctivitis market by industry participants. In combination for use in geometric surveying, SWOT analysis, statistical analyses, PESTLE analysis, and real-time testing approaches are utilized. It comprises a study of major participants in the industry and their latest market policies to enable new market participants, stakeholders, and shareholders to build successful company plans. Ask For
2020 Allergic Conjunctivitis Market Report- Trends, Top Manufactures, Size, Mark …
The research reports on Allergic Conjunctivitis Market report gives detailed overview of factors that affect global business scope. Allergic Conjunctivitis Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. Allergic Conjunctivitis Market report contains emerging players analyze data including competitive situations, sales, revenue and market share of top manufacturers. Get FREE
Deadline on May 11th coming up in Lawsuit for Investors in Allakos Inc. (NASDAQ: …
A deadline is coming up on May 11, 2020 in the lawsuit filed for certain investors of Allakos Inc. (NASDAQ: ALLK) over alleged securities laws violations by Allakos Inc. (NASDAQ: ALLK). Investors who purchased shares of Allakos Inc. (NASDAQ: ALLK) have certain options and there are strict and short deadlines running. Deadline: May 11, 2020. NASDAQ: ALLK stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According